US Bancorp
FLNA

US Bancorp’s Filana Therapeutics FLNA Stock Holding History

US Bancorp’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105 Buy
+88
New +$125 ﹤0.01% 4129
2025
Q2 		– Sell
-81
Closed -$122 – 4302
2025
Q1 		$122 Sell
81
-185
-70% -$467 ﹤0.01% 4134
2024
Q4 		$628 Sell
266
-57
-18% -$1K ﹤0.01% 4009
2024
Q3 		$9.51K Sell
323
-279
-46% -$6.42K ﹤0.01% 3381
2024
Q2 		$7.43K Sell
602
-2,303
-79% -$48.5K ﹤0.01% 3407
2024
Q1 		$58.9K Sell
2,905
-128
-4% -$2.95K ﹤0.01% 2601
2023
Q4 		$68.3K Buy
3,033
+361
+14% +$7.63K ﹤0.01% 2510
2023
Q3 		$44.5K Sell
2,672
-4,886
-65% -$96.8K ﹤0.01% 2506
2023
Q2 		$185K Buy
7,558
+105
+1% +$2.53K ﹤0.01% 1903
2023
Q1 		$180K Sell
7,453
-778
-9% -$21.6K ﹤0.01% 1909
2022
Q4 		$243K Buy
8,231
+1,477
+22% +$53.1K ﹤0.01% 1753
2022
Q3 		$282K Buy
6,754
+1,715
+34% +$46.3K ﹤0.01% 1671
2022
Q2 		$142K Buy
5,039
+799
+19% +$20.2K ﹤0.01% 2036
2022
Q1 		$157K Buy
4,240
+482
+13% +$20.4K ﹤0.01% 2072
2021
Q4 		$164K Buy
3,758
+342
+10% +$17.9K ﹤0.01% 2058
2021
Q3 		$212K Buy
3,416
+1,925
+129% +$161K ﹤0.01% 1941
2021
Q2 		$127K Buy
1,491
+891
+149% +$47.7K ﹤0.01% 2180
2021
Q1 		$27K Buy
+600
New +$23.6K ﹤0.01% 2890

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

US Bancorp's FLNA Position: Q2 2026 in Review

US Bancorp opened a new position in Filana Therapeutics (FLNA) in Q2 2026: 88 shares worth $105. The stake represents ﹤0.01% of the portfolio and ranks #4129 among its holdings. This is a return to the name: US Bancorp previously reported a position in FLNA as recently as Q1 2025.

US Bancorp first reported a position in FLNA in Q1 2021 and has held it in 18 quarters since. The position peaked at $282K in Q3 2022. 85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • US Bancorp held 88 shares of Filana Therapeutics worth $105 as of Q2 2026.
  • Filana Therapeutics was a new US Bancorp position in Q2 2026.
  • Filana Therapeutics made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #4129 holding.
  • US Bancorp first reported a position in Filana Therapeutics in Q1 2021 and has held it in 18 quarters since.
  • US Bancorp's Filana Therapeutics position peaked at $282K in Q3 2022.
  • 85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.